Walleye Trading’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-11,062
Closed -$757K – 4150
2024
Q4
$757K Sell
11,062
-2,295
-17% -$160K ﹤0.01% 2328
2024
Q3
$961K Buy
+13,357
New +$942K ﹤0.01% 2126
2023
Q4
– Sell
-1,702
Closed -$172K – 5110
2023
Q3
$172K Buy
+1,702
New +$196K ﹤0.01% 3705
2021
Q2
– Sell
-3,072
Closed -$401K – 5191
2021
Q1
$401K Buy
+3,072
New +$370K ﹤0.01% 2886
2015
Q3
– Sell
-100
Closed -$6K – 5018
2015
Q2
$6K Buy
+100
New +$5.39K ﹤0.01% 4438

Other funds holding CNMD

Walleye Trading's CNMD Position: Q1 2025 in Review

Walleye Trading sold out of CONMED (CNMD) in Q1 2025, closing a stake of 11,062 shares — an estimated $757K sold.

Walleye Trading first reported a position in CNMD in Q2 2015 and held it in 5 quarters. The position peaked at $961K in Q3 2024. 280 funds tracked by Wall St. Rank hold CNMD as of Q1 2025.

  • Walleye Trading reported no remaining CONMED position as of Q1 2025 after selling out during the quarter.
  • Walleye Trading sold 11,062 CONMED shares in Q1 2025, an estimated $757K.
  • Walleye Trading first reported a position in CONMED in Q2 2015 and held it in 5 quarters.
  • Walleye Trading's CONMED position peaked at $961K in Q3 2024.
  • 280 funds tracked by Wall St. Rank held CONMED as of Q1 2025.

Based on Walleye Trading's 13F filing for Q1 2025, filed 14 May 2025.